Most Healthcare Payer Execs Uncertain About Benefit

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Most Healthcare Payer Execs Uncertain About Benefit Exchanges Being Ready on October 1st; KPMG Study

NEW YORK, Sept. 27, 2013 (GLOBE NEWSWIRE) -- Sixty-five percent of healthcare payer executives expressed a lack of confidence that health benefit exchanges would be operational at the onset of open enrollment on October 1, according to a recent poll conducted by KPMG LLP, the audit, tax and advisory firm.

In the KPMG poll of more than 80 executives from the healthcare payer community, conducted in the weeks leading up to implementation, 32 percent said "No" when asked if the exchanges would be ready on October 1 st , while 33 percent responded "Maybe, but I have my doubts." 35 percent were confident that the exchanges would be fully functional on October 1 st . 

"Despite their trepidation, nearly 80 percent of respondents felt that their companies are or are close to being ready to process healthcare benefit exchange transactions on day one," said Ed Giniat, national sector leader of KPMG's Healthcare and Life Sciences practice. "Payers largely view the inception of the health benefits exchange as a necessary change in our business landscape and believe it can be a way to improve their business and increase their membership." 

Evidence of this mindset was displayed in a separate question, where 35 percent of respondents characterize healthcare benefit exchanges as necessary change for America's healthcare system. Twenty-six percent viewed healthcare benefit exchanges as a risk management issue that needed to be carefully managed, while 12 percent thought it provided a way to improve their business. Twenty-seven percent were still unsure of the impact of healthcare benefit exchanges.

Expected Short Term Challenges

More than half (51 percent) of payers cited a mix of issues surrounding eligibility, customer service, enrollment and payment processing, and potential financial impact as the greatest operational challenge to their businesses once the exchanges go online. Of those choices, one quarter singled out new patient eligibility as the biggest operational obstacle.

"With the potential of more than 30 million Americans being added to our healthcare infrastructure, determining who is eligible and what they are eligible for presents a significant short term burden to the new system," said Joseph Parente, principal and management consulting leader for KPMG's Healthcare and Life Sciences practice. "Companies must get the set up right or make quick adjustments in order to prevent future bottlenecks in the system when enrollment and payment processing starts to take shape."

When it comes to their customer service preparation, payers for the most part are ready to tackle the incoming wave of interactions through a mix of methods. The majority of payers (42 percent) stated that they will be ready for enrollment by 2014. Those that source their customer service outside their walls indicated that their service partners are ready for open enrollment and will continue to work with them on a "going forward" basis (26 percent). One quarter of respondents shared that they are not as prepared as they would like to be.

Uncertainty Over Long Term

31 percent of respondents were uncertain of how the exchanges would perform over the next 12 months. Payers that expressed confidence believed that exchanges would lead to more efficient and effective cost structures, the creation of more standardized products and services, greater data integration, and the addition of more customers and upselling possibilities (23 percent selected all of the above, those that selected one of those sentiments ranged between 10 and 14 percent).

"The next 12 months will present significant challenges for healthcare payers; not only will they need to react to the changing landscape, they will also have to develop strategies that get them closer to their customers and take advantage of the new tools that can help separate themselves from competitors," concluded Giniat.

About the study

KPMG LLP commissioned DistilNFO, a publication house that operates seven industry vertical focused publications that reaches healthcare, retail and IT executives worldwide, to gauge the opinions of healthcare payer executives on the coming implementation of healthcare benefit exchanges. The survey was conducted online from August 20 th to September 19 th , 2013. For more information on DistilNFO, please visit http://www.distilnfo.com .

About KPMG Healthcare and Life Sciences

KPMG LLP is a leader in healthcare convergence, assisting organizations across the Healthcare and Life Science ecosystem to work together in new ways to transform the business of healthcare. With more than 1,500 U.S. partners and professionals supported by a global network of in 150 countries, we offer a market leading portfolio of tools and services focused on helping our clients adapt to regulatory change; design and implement new business models, and leverage technology, data and analytics to guide them on their path to convergence. Click here for more information on KPMG's thought leadership in healthcare and life sciences.

About KPMG LLP

KPMG LLP, the audit, tax and advisory firm ( www.kpmg.com/us ), is the U.S. member firm of KPMG International Cooperative ("KPMG International."). KPMG International's member firms have 145,000 people, including more than 8,000 partners, in 152 countries.

Matt Caruso KPMG LLP 201-307-7275 Twitter: @mattcaruso07014

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 11

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 7

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 7

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 11

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 4

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 10

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 6

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 10

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 5

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

Chart Industries Transitions to New Leadership in Upcoming Merger

Updated Category News Views 231

Chart Industries Announces Leadership Change Chart Industries (NYSE: GTLS) is taking significant steps toward a future transition as CEO Jill Evanko has announced plans to assume a senior advisor role starting in early 2026. This change comes as she prepares to take on a new executive opportunity within a privately owned company. Evanko has been essential in steering the...

Continue Reading
Understanding Debtors: Insights into Realkredit Danmark A/S

Updated Category News Views 299

Understanding Debtors: Key Insights from Realkredit Danmark A/S At the heart of any effective financial institution is a reliable understanding of its debtors. Realkredit Danmark A/S, a prestigious name in the financial landscape, recently made available a detailed breakdown of its debtors. This information is crucial for various stakeholders, including investors,...

Continue Reading
Cryptocurrency Market Update: Bitcoin Droops under $59K with ETF Inflows Soaring

Updated Category News Views 148

Bitcoin's Recent Performance The cryptocurrency market has been lively lately, especially with Bitcoin recently falling below the $59,000 threshold. Investors had been optimistic, especially since the cryptocurrency saw a remarkable $436 million in net ETF inflows just last week. This significant influx signals that institutional interest in cryptocurrencies is still...

Continue Reading
Enhancing Specialized Care for ARFID Treatment with Emily Program

Updated Category News Views 169

Introduction to The Emily Program and ARFID The Emily Program is making significant strides in specialized care for individuals with Avoidant/Restrictive Food Intake Disorder (ARFID). This condition, often misunderstood, has recently begun to garner more attention from healthcare experts. In response to this need, The Emily Program is offering advanced treatment...

Continue Reading
Investigation of Alleged Securities Fraud at 3D Systems Unfolds

Updated Category News Views 167

Overview of Legal Actions Against 3D Systems Corporation Recently, investors in 3D Systems Corporation have found themselves entangled in a potential securities fraud lawsuit. This case serves as a cautionary tale, highlighting the importance of transparency and integrity in corporate communication. The allegations stem from assertions that the company made misleading...

Continue Reading